Annexin V inhibits lipopolysaccharide-induced procoagulant activity on human monocytes

Thrombosis Research

Volumn 114, Issue 1, 2004, Pages 45-49

  Sato, Hirokazu ^a   Konishi, Yoshitomo ^a   Tanaka, Hidenori ^a   Takahashi, Osamu ^a   Tanaka, Toshinobu ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Annexin V; Ca2+ phospholipid binding protein; Lipopolysaccharide; Monocyte; Procoagulant activity

Indexed keywords

CALCIUM BINDING PROTEIN; CHROMOGENIC SUBSTRATE; LIPOCORTIN 5; LIPOPOLYSACCHARIDE; PROCOAGULANT;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CELL; CELL SURFACE; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IC 50; LEUKOCYTE COUNT; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ADULT; BLOOD COAGULATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; WHOLE BLOOD COAGULATION TIME;

EID: 3242694486     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.04.012     Document Type: Article

References (13)

1. Rivers R.P.A., Hathaway W.E., Weston W.L. The endotoxin-induced coagulant activity of human monocytes. Br. J. Haematol. 31:1975;311-316
2. Schwartz B.S., Levy G.A., Edgington T.S. Immune complex-induced human monocyte procoagulant activity: II. Cellular kinetics and metabolic requirements. J. Immunol. 128:1982;1037-1042
3. Miller C.L., Graziano C., Lim R.C., Chin M. Generation of tissue factor by patients' monocytes; correlation to thromboembolic complications. Thromb. Haemost. 41:1981;489-495
4. Hardaway R.M. A review of septic shock. Am. Surgeon. 66:2000;22-29
5. Iwasaki A., Suda M., Nakao H., Nagoya T., Saino Y., Arai K., et al. Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein. J. Biochem. 102:1987;1261-1273
6. Iwasaki A., Suda M., Watanabe M., Nakao H., Hattori Y., Nagoya T., et al. Structure and expression of cDNA for calphobindin II, a human placental coagulation inhibitor. J. Biochem. 106:1989;43-49
7. Maki M., Shidara Y., Sato H. Placental annexins - isolation, characterization and possible functions. Annexins. 1992;153-164 Portland Press, London
8. Reutelingsperger C.P.M., Kop J.M.M., Hornstra G., Hemker H.C. Purification and characterization of a novel protein from bovine aorta that inhibits coagulation: inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur. J. Biochem. 173:1988;171-178
9. Ohyama N., Sato H., Tanaka T. Epidermal growth factor enhances lipopolysaccharide-induced procoagulant activity on the cell surface of endothelial cells. Blood Coagul. Fibrinolysis. 12:2001;385-389
10. Surprenant Y.M., Zuckerman S.H. A novel microtiter plate assay for the quantitation of procoagulant activity on adherent monocytes, macrophage and endothelial cells. Thromb. Res. 53:1989;339-346
11. Maki M., Shidara Y., Sato H. Calphobindins (Annexins). Tanaka K. Recent advances in thrombosis and fibrinolysis. 1991;59-72 Academic Press, Tokyo
12. Suomela H., Blomback M., Blomback B. The activation of factor X evaluated by using synthetic substrates. Thromb. Res. 1:1994;267-281
13. Baker P., Joshi M., Luddington R. Monocyte procoagulant activity: development of a microtitre plate chromogenic assay. Br. J. Biomed. Sci. 51:1994;328-331